Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Equine Vet J ; 51(3): 401-407, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-30203854

RESUMO

BACKGROUND: Corticosteroids are the most potent drugs for the control of severe equine asthma, but adverse effects limit their chronic systemic administration. Inhaled medications allow for drug delivery directly into the airways, reducing the harmful effects of these drugs. OBJECTIVES: To evaluate the efficacy of inhaled budesonide specifically formulated for the equine use and administered by a novel inhalation device in horses with severe asthma. STUDY DESIGN: Experimental studies in horses with naturally occurring asthma with cross-over, randomised, blinded experimental designs. METHODS: In Study 1, budesonide (1800 µg twice daily) administered using a novel Respimat® based inhaler was compared to i.v. dexamethasone (0.04 mg/kg). In Study 2, 3 doses of budesonide (450, 900, and 1800 µg) were compared to oral dexamethasone (0.066 mg/kg). Lung function, bronchoalveolar fluid cytology (Study 1), CBC, serum chemistry, and serum cortisol and adrenocorticotropic hormone (ACTH) values were evaluated. RESULTS: In Study 1, there was a marked and significant improvement in the lung function of all horses treated with budesonide and dexamethasone. Neutrophil percentages in bronchoalveolar fluid decreased in all horses treated with dexamethasone and in four of six horses treated with budesonide. Serum cortisol and blood ACTH concentrations decreased with both treatments. In Study 2, there was a significant improvement in the lung function with all dosages of budesonide, and the effects of higher dosages were comparable to those of dexamethasone. Dexamethasone and budesonide at the two higher dosages induced a significant decrease of cortisol concentrations. MAIN LIMITATIONS: The Respimat® based inhaler is not currently commercially available. CONCLUSIONS: Administration of budesonide with the Respimat® based inhaler provided dose-dependent relief of airway obstruction in horses with severe asthma, but also a suppression of serum cortisol.


Assuntos
Anti-Inflamatórios/uso terapêutico , Asma/veterinária , Budesonida/uso terapêutico , Doenças dos Cavalos/tratamento farmacológico , Animais , Anti-Inflamatórios/administração & dosagem , Asma/tratamento farmacológico , Budesonida/administração & dosagem , Estudos Cross-Over , Relação Dose-Resposta a Droga , Cavalos , Distribuição Aleatória
2.
J Vet Intern Med ; 26(6): 1419-26, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22925172

RESUMO

BACKGROUND: Systemic inflammation in horses with heaves is poorly characterized. OBJECTIVES: To assess acute phase proteins (APP) and inflammatory cytokine profiles in serum of healthy horses and horses with heaves. ANIMALS: Six healthy horses and 6 heaves-affected horses belonging to the University of Montreal. METHODS: Prospective, observational study. Healthy and heaves-affected control horses were exposed to a 30-day natural challenge with hay and straw to induce clinical exacerbation of heaves. Serum samples were obtained by venipuncture before (T0) as well as after 7 (T7) and 30 days (T30) of stabling. Serum APP (haptoglobin, serum amyloid A protein [SAA] and C-reactive protein [CRP]) and cytokines (IL-2, IL-4, IFN-α, IL-10, IFN-γ, and CCL-2) were measured using singleplex or multiplex ELISA. RESULTS: Serum haptoglobin concentrations were significantly higher in heaves-affected horses at all time points with no overlap with those of healthy controls. They were also significantly increased by antigen challenge in both controls (T7) and horses with heaves (T7 and T30). Serum SAA was detected more frequently in heaves-affected horses compared with healthy controls at T7. There was no difference in serum concentrations of CRP, IL-10, IFN-γ, and CCL-2 between groups, whereas IL-2, IL-4, and IFN-α remained undetectable in all samples. CONCLUSIONS AND CLINICAL IMPORTANCE: In heaves, haptoglobin is a marker of both acute and chronic systemic inflammation, whereas high concentrations of SAA indicate acute inflammation.


Assuntos
Proteínas Sanguíneas/metabolismo , Citocinas/sangue , Doenças dos Cavalos/sangue , Inflamação/veterinária , Doença Pulmonar Obstrutiva Crônica/veterinária , Animais , Biomarcadores/sangue , Citocinas/genética , Citocinas/metabolismo , Feminino , Regulação da Expressão Gênica/fisiologia , Cavalos , Inflamação/sangue , Masculino , Doença Pulmonar Obstrutiva Crônica/sangue , Estações do Ano
3.
Cad Saude Publica ; 17(4): 957-68, 2001.
Artigo em Português | MEDLINE | ID: mdl-11514877

RESUMO

This article focuses on the AIDS mortality profile as related to socioeconomic and geographic variables, as well as evaluating the impact of deaths from AIDS in the State of Rio de Janeiro. The analysis included all death certificates for residents of the State from 1991-1995, 10,024 of which had AIDS recorded as the primary cause of death. In the 20-49-year age bracket, among individuals who had died of AIDS, the proportion of those with university schooling (14%) and the proportion of single individuals (75%) were greater than the respective proportions for all other causes of death (5.4% and 56.3%). For the population as a whole, the AIDS mortality rate increased from 1991 to 1995, from 20.6/100,000 to 30.2/100,000 for males and from 3.7/100,000 to 7.9/100,000 for females. For the year 1995 in the 20-49-year bracket, considering the 17 groups of causes from the ICD-9, AIDS was the third most common cause of death among men and the fifth most common among women. The proportion of Potential Loss of Life Years up to 65 years as a function of AIDS increased from 1991 to 1995, from 3.4% to 4.7% for men and from 1.4% to 2.9% for women. During this same period there was also an increase in the number of counties in the State of Rio de Janeiro with reported deaths from AIDS.


Assuntos
Síndrome da Imunodeficiência Adquirida/mortalidade , Adolescente , Adulto , Idoso , Brasil/epidemiologia , Causas de Morte , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Características de Residência , Fatores Socioeconômicos
4.
Cad Saude Publica ; 17(3): 617-26, 2001.
Artigo em Português | MEDLINE | ID: mdl-11395798

RESUMO

This study aimed to estimate and evaluate the under-recording of AIDS cases that evolved to death. From 1991 to 1995, the Mortality Information System recorded 9,213 adult deaths due to AIDS, related by name, date of birth, and date of death to 15,505 AIDS recorded by the Disease Data Registration System from 1982 to 1996. This procedure showed that 51.9% of AIDS deaths recorded in the period were not recorded as AIDS cases as they should have been. Univariate and multivariate analysis showed that women had a greater chance of under-recording than men (OR = 1.27). A lower probability of proper recording was observed in individuals with less schooling, and illiterates had a two-fold chance of not being properly recorded, as compared to individuals with college degrees. Deaths that occurred in health facilities classified as private units had a greater probability of not being recorded than those occurring elsewhere (mainly those classified as public reference units) (OR = 2.58). Deaths occurring in the city of Rio de Janeiro had a greater probability of under-recording than those in other cities (OR = 2.20).


Assuntos
Síndrome da Imunodeficiência Adquirida/mortalidade , Atestado de Óbito , Prontuários Médicos/estatística & dados numéricos , Síndrome da Imunodeficiência Adquirida/epidemiologia , Adolescente , Adulto , Análise de Variância , Brasil/epidemiologia , Escolaridade , Feminino , Humanos , Sistemas de Informação , Masculino , Estado Civil , Registro Médico Coordenado , Pessoa de Meia-Idade , Razão de Chances , Vigilância da População , Sistema de Registros
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...